Clinical Trials Logo

Cancer of Bladder clinical trials

View clinical trials related to Cancer of Bladder.

Filter by:
  • None
  • Page 1

NCT ID: NCT04127318 Withdrawn - Immunotherapy Clinical Trials

Low-moderate Intensity Pedaling During Immunotherapy Administration

Start date: January 31, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility pedaling using an under-the desk bike during immunotherapy infusions. Also, the study hopes to evaluate how pedaling impacts quality of life and treatment response biomarkers. Lastly, the study will evaluate the relationships between treatment response and muscle mass which is evaluated with computerized tomography (CT) scans.

NCT ID: NCT03335059 Terminated - Bladder Cancer Clinical Trials

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.

RITE-USA
Start date: April 4, 2019
Phase: Phase 3
Study type: Interventional

This study will determine whether Synergo® RITE + MMC treatment is efficacious as second-line therapy for CIS NMIBC BCG-unresponsive patients with or without papillary NMIBC, through examination of the complete response rate (CRR) and disease-free duration for complete responders. The study will also explore progression-free survival time, bladder preservation rate, and overall survival time. The study will address an unmet need to identify a treatment effective in both ablating the disease and providing a prolonged disease-free period for patients. Ideally, the treatment will delay progression to invasive disease, thus preserving the bladder.

NCT ID: NCT03133286 Recruiting - Cancer Clinical Trials

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

RADIANT
Start date: April 6, 2017
Phase:
Study type: Observational

Collect blood samples and associated clinical data prior to, during, and post radiation treatment.

NCT ID: NCT03063255 Completed - Cancer of Bladder Clinical Trials

Comparison of Obturator Nerve Blockade and Neuromuscular Blockade

Start date: April 25, 2017
Phase: Phase 4
Study type: Interventional

Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.